BA
Brittany Ashlock
Physician · Permanente Medical Group Inc
Credentials: · · ·
History
- Present
Permanente Medical Group Inc
Research
Virology · 2005 · 97 citations
CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma
Blood · 2013 · 62 citations
Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma
Journal of Clinical Investigation · 2013 · 59 citations
5 papers
3 papers
- HL
2 papers
2 papers
1 paper
1 paper
1 paper
- LC
1 paper
